Latest Security News

American Tungsten & Antimony Ltd (ASX: AT4) has named Casper Adson as CEO to spearhead its metallurgical strategy, aiming to transform its US antimony and tungsten assets into defence-grade products and tap into US government funding.

Eagle Mountain Mining’s joint venture with Nittetsu has contracted Boart Longyear for a 6,000-metre drilling campaign at Oracle Ridge, marking a significant step in exploring near-mine copper extensions and testing new geophysical targets.

Toi Foundation has reopened its community consultation on the proposed sale of TSB Bank shares to Heartland Group Holdings due to a procedural error, pushing the trustee decision to August and delaying the merger timeline.

White Energy confirms ASX listing rules exemption for its proposed US metallurgical and Surat Basin coal assets acquisition, advancing due diligence and capital raising plans.

The Daintree Hybrid Opportunities Active ETF (ASX: DHOF) is making its final distribution and redemption payments as it completes wind-up, returning over $9.64 per unit to unitholders in total.

Qoria Limited’s acquisition by Aura Consolidated Group has become legally effective following Federal Court approval, with Qoria shares suspended and Aura CHESS Depositary Interests set for issuance in mid-July.

Qube Holdings' acquisition by Rubik Australia is now legally effective following Supreme Court approval, with trading suspension imminent. The company has declared a fully franked special dividend of $0.3465 per share, payable mid-July, ahead of the scheme implementation in August.

Larvotto Resources rejects Austral Resources' non-binding bid for Hammer Metals, underscoring its binding scheme and operational strengths including imminent production at Hillgrove.

Proteomics International has won a key US patent for its PromarkerEndo blood test, bolstering its commercial foothold in the world’s largest healthcare market. The patented technology offers a non-invasive, accurate diagnosis of endometriosis, a condition that currently takes years to detect.

Island Pharmaceuticals is progressing its broad-spectrum antiviral Galidesivir amid a severe Ebola outbreak, securing government approvals in Uganda and outlining a dual clinical and regulatory development pathway targeting multiple deadly filoviruses.

IperionX has secured approximately US$50 million through a public offering of American Depositary Shares, targeting the scale-up of its titanium production and expansion of key US facilities.

Taiton Resources has finalised a placement of 1.14 million shares at 7 cents each, including shares and options issued to insiders following shareholder approval.